Jun 13, 2025
1:20
For every 20 shares held, investors received 1. The price per share adjusted from $0.38 to $0.02.
The split itself did not change the total investment value.
CERo Therapeutics Holdings, Inc. (CERO) trades on the Other OTC in the Biotechnology industry.
CERo Therapeutics Holdings, Inc. company overviewThe latest split shown was on June 13, 2025. It was a 1-for-20 reverse split, so shareholders received 1 share for every 20 they held.
This history records 2 reverse splits between January 8, 2025 and June 13, 2025.